IEEE/ACM Trans Comput Biol Bioinform
November 2024
Due to their safety, high activity, and plentiful sources, antioxidant peptides, particularly those produced from food, are thought to be prospective competitors to synthetic antioxidants in the fight against free radical-mediated illnesses. The lengthy and laborious trial-and-error method for identifying antioxidative peptides (AOP) has raised interest in creating computational-based methods. There exist two state-of-the-art AOP predictors; however, the restriction on peptide sequence length makes them inviable.
View Article and Find Full Text PDFHigh-affinity ligand peptides for ion channels are essential for controlling the flow of ions across the plasma membrane. These peptides are now being investigated as possible therapeutic possibilities for a variety of illnesses, including cancer and cardiovascular disease. So, the identification and interpretation of ligand peptide inhibitors to control ion flow across cells become pivotal for exploration.
View Article and Find Full Text PDFThe escalating global incidence of cancer poses significant health challenges, underscoring the need for innovative and more efficacious treatments. Cancer immunotherapy, a promising approach leveraging the body's immune system against cancer, emerges as a compelling solution. Consequently, the identification and characterization of tumor T-cell antigens (TTCAs) have become pivotal for exploration.
View Article and Find Full Text PDFBackground: The most commonly used therapy currently for inflammatory and autoimmune diseases is nonspecific anti-inflammatory drugs, which have various hazardous side effects. Recently, some anti-inflammatory peptides (AIPs) have been found to be a substitute therapy for inflammatory diseases like rheumatoid arthritis and Alzheimer's. Therefore, the identification of these AIPs is an emerging topic that is equally important.
View Article and Find Full Text PDFThe cytokine interleukin-4 (IL-4) plays an important role in our immune system. IL-4 leads the way in the differentiation of naïve T-helper 0 cells (Th0) to T-helper 2 cells (Th2). The Th2 responses are characterized by the release of IL-4.
View Article and Find Full Text PDF